By James J. Gormley and Frank Herd, Jr.
Starting at 2:00 p.m. today, May 24th, the Senate will vote on 17 amendments to the Food and Drug Administration Safety and Innovation Act (S. 3187) – also known as the FDA User Fee bill (S.3187) – followed by a vote on final passage, including anti-supplement Amendment No. 2127 from Senator Dick Durbin [D-IL].
Sound familiar? It should – you helped us defeat this move last year when an expanded version of it appeared as S. 1310, Durbin’s Dietary Supplement Labeling Act of 2011. Please use the link below to call your Senators right away and urge them to oppose Durbin’s amendment when it’s introduced, and to focus instead on holding unscrupulous food companies accountable to our existing system of consumer protections.
Last year’s S. 1310 was a misguided response to marketing tactics by unscrupulous food companies trying to circumvent FDA standards – and so is Sen. Durbin’s Amendment No. 2127 to be voted on today.
This amendment would create a totally new law!
That’s right, a new law that would circumvent: the guidelines outlined even in the fatally flawed NDI Draft Guidance; the facility registration rules already in place under the Bioterrorism Act of 2001; and the over 35,000 product labels already on file with the FDA and the US National Library of Medicine.
The product registration nightmare of this new law would require burdensome and unnecessary registration of all safe dietary supplements, moving supplement labeling submission requirements that much closer to drug-like regulations that we see in Canada and Europe today.
Tens of thousands of products would have too be removed from store shelves in order to comply with new, completely unwarranted 30-day post market product and label registration requirements!!
Leave a voicemail, or a message with an aide saying that you have learned that there will be a vote today on Senator Durbin’s amendment to S. 3187, one that unfairly targets makers of dietary supplements and that your Senator should oppose it.
Please also ask your Senator to focus instead on holding accountable the duplicitous companies looking to circumvent existing regulations.
Keep an eye on your email box and on www.citizens.org for updates as this issue develops.